ST-503 will be evaluated in a phase 1/2 trial with the first patient scheduled to receive the therapy in the coming months. The Food and Drug Administration (FDA) has granted Fast Track designation to ...

Small fiber neuropathy (SFN) is a chronic and debilitating condition caused by damage to peripheral sensory nerves, which are responsible for pain, temperature sensation and autonomic functions.

A $3.6 million award from the National Institutes of Health will allow neurosurgical, neurology and neuroscience researchers at The Ohio State University Wexner Medical Center and College of Medicine ...

Sangamo Therapeutics Inc. has received IND clearance from the FDA for ST-503, an investigational epigenetic regulator for the treatment of intractable pain due to idiopathic small fiber neuropathy ...

Laser treatment is an emergent therapy for many conditions including neuropathy. It stimulates nerve cells and promotes regeneration, helping alleviate neuropathy symptoms. There is much controversy ...

Shock wave therapy uses sound energy waves to improve blood flow and promote healing. This treatment has been linked to reduced pain and overall symptom improvement for people with diabetic neuropathy ...